Medicare Enrolled
Dr. Mehrdad Rezaee, MD PHD
Cardiovascular Disease · San Jose, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rezaee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rezaee?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rezaee
Dr. Mehrdad Rezaee is a cardiovascular disease specialist in San Jose, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rezaee performed 4,959 Medicare services across 1,407 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rezaee received a total of $12,448 from 38 pharmaceutical and/or device companies across 291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rezaee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 19% volume in CA
$12,448 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,959
Medicare services
Top 19% in CA for cardiovascular disease
1,407
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~248 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Adenosine injection, 1 mg Administration of a 1 mg dose of adenosine medication. This code is specifically for adenosine and excludes adenosine phosphate compounds. |
2,598 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
546 | $111 | $403 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
484 | $0 | $1 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
241 | $159 | $501 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
134 | $187 | $800 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 116 | $402 | $700 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
96 | $23 | $100 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
94 | $13 | $60 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
93 | $25 | $108 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
66 | $70 | $300 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
61 | $40 | $151 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
60 | $70 | $300 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
58 | $1,554 | $6,000 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
55 | $156 | $700 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
43 | $71 | $340 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
39 | $23 | $100 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
39 | $936 | $3,000 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $151 | $600 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
23 | $164 | $4,000 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
19 | $436 | $2,000 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
19 | $191 | $800 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $83 | $384 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
16 | $107 | $350 |
| New patient office visit, complex (60-74 min) | 13 | $207 | $700 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.9% high complexity
56.5% medium
25.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,448
Total received (2018-2024)
Avg $1,778/year across 7 years
Top 24% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
291
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,011 (96.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$314 (2.5%)
Scientific / Research
Research funding and grants
$123 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,511
2023
$1,148
2022
$1,384
2021
$1,657
2020
$275
2019
$1,134
2018
$3,338
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$2,224
PFIZER INC.
$209
Actelion Pharmaceuticals US, Inc.
$188
ShockWave Medical, Inc
$155
Novo Nordisk Inc
$119
Novartis Pharmaceuticals Corporation
$88
Kiniksa Pharmaceuticals International, plc
$67
Amgen Inc.
$60
Philips North America LLC
$52
Teleflex LLC
$48
E.R. Squibb & Sons, L.L.C.
$46
ABIOMED
$43
Esperion Therapeutics, Inc.
$42
Boston Scientific Corporation
$37
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$32
Merck Sharp & Dohme LLC
$30
Getinge USA Sales, LLC
$25
Janssen Pharmaceuticals, Inc
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Terumo Medical Corporation
$15
Top 3 companies account for 74.6% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$4,649
Medtronic Vascular, Inc.
$2,386
Philips Electronics North America Corporation
$1,097
PFIZER INC.
$713
Actelion Pharmaceuticals US, Inc.
$514
E.R. Squibb & Sons, L.L.C.
$388
AstraZeneca Pharmaceuticals LP
$241
Novartis Pharmaceuticals Corporation
$239
Janssen Pharmaceuticals, Inc
$223
ShockWave Medical, Inc
$190
Bayer HealthCare Pharmaceuticals Inc.
$173
Merck Sharp & Dohme LLC
$151
Gilead Sciences, Inc.
$147
Abbott Laboratories
$124
Novo Nordisk Inc
$119
Akcea Therapeutics, Inc.
$98
Boston Scientific Corporation
$96
Amgen Inc.
$88
Cardinal Health 200, LLC
$69
Kiniksa Pharmaceuticals International, plc
$67
Allergan Inc.
$64
Terumo Medical Corporation
$58
Shockwave Medical, Inc
$57
Philips North America LLC
$52
Teleflex LLC
$48
ABIOMED
$43
Esperion Therapeutics, Inc.
$42
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$37
BIOTRONIK INC.
$37
PORTOLA PHARMACEUTICALS, INC.
$35
ACIST MEDICAL SYSTEMS, INC.
$35
CARDIVA MEDICAL, INC.
$34
Penumbra, Inc.
$33
Regeneron Healthcare Solutions, Inc.
$27
Getinge USA Sales, LLC
$25
Kowa Pharmaceuticals America, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$16
ASAHI INTECC USA, INC.
$14
Top 3 companies account for 65.3% of all-time payments
Associated products mentioned in payments ›
(5027) Intact Vascular Und · (6571) Eagle Eye · (8333) IGT D Coronary · (9266) ELCA · (9267) AngioSculpt CV RX · (BR0) Coronary Atherectomy · 3F · ANDEXXA · ANGIO-SEAL · ASAHI PTCA Guide Wire · AZURE XT DR MRI SURESCAN · Adempas · Arcalyst · Assurity Pacemaker · BOSENTAN TABLETS · BRILINTA · BYSTOLIC · CAMZYOS · CARDIOSAVE HYBRID · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CLOSUREFAST · COREVALVE EVOLUT R · CVI SYSTEMS · Confirm Rx · CoreValve Evolut · ELIQUIS · ENTRESTO · FLEXTOME · Flextome Cutting Balloon · GLIDESHEATH SLENDER · GLIDEWIRE · GUIDELINER · IGT D Coronary · IGT_D Coronary · Image Guided Therapy Devices _ Coronary · Impella · Indigo System · JOT DX · LEQVIO · LINQ II · Letairis · LifeVest · Livalo · MICRA · Micra · Mitra Clip system · NEXLETOL · NURTEC ODT · OPSUMIT · OPSUMIT MACITENTAN · OPTICROSS · PRALUENT · Repatha · Resolute · SELECTSECURE · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Solia · TEGSEDI · TYPE B PLUG · Tryton Side Branch Stent · TurboHawk · UPTRAVI · VERQUVO · VYNDAQEL · Verquvo · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
207
Per 100K population
10.9
County median income
$159,674
Nearest hospital
SANTA CLARA VALLEY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rezaee is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rezaee experienced with adenosine injection, 1 mg?
Based on Medicare claims data, Dr. Rezaee performed 2,598 adenosine injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rezaee receive payments from pharmaceutical companies?
Yes. Dr. Rezaee received a total of $12,448 from 38 companies across 291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rezaee's costs compare to other cardiologists in San Jose?
Dr. Rezaee's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rezaee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in San Jose
Browse cardiologists in San Jose ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Philips Electronics North America Corporation Payments to Doctors
See all physicians who received payments from Philips Electronics North America Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology